ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,042, issued on March 17.

"Methods and compositions for treating neurological conditions" was invented by Stuart A. Lipton (Rancho Santa Fe, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods for treating juvenile onset neurological conditions, such as autism (ASD), intellectual disability, or epilepsy, with an inhibitor of N-methyl-D-aspartate receptor (NMDAR). The inhibitor may be NitroSynapsin or a derivative thereof."

The patent was filed on Dec. 2, 2022, under Application No. 18/061,081.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=...